Pfizer (PFE) Current Assets (2009 - 2026)
Pfizer (PFE) reported Current Assets of $42.8 billion for Q1 2026, down 6.63% year-over-year from $45.9 billion in Q1 2025, and little changed on a QoQ basis from $42.9 billion in Q4 2025.
Pfizer (PFE) has 18 years of Current Assets data on file, last reported at $42.8 billion in Q1 2026.
- Quarterly Current Assets fell 6.63% year-over-year to $42.8 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $42.8 billion (down 6.63% YoY) and the FY2025 annual result came in at $42.9 billion, down 14.81% from the prior year.
- Current Assets was little changed at $42.8 billion in Q1 2026 per PFE's latest filing, from $42.9 billion in the prior quarter.
- Across five years, Current Assets topped out at $74.0 billion in Q4 2023 and bottomed at $5.9 billion in Q4 2022.
- The 5-year median for Current Assets is $45.9 billion (2025), against an average of $48.0 billion.
- The widest annual swing landed in 2023, when Current Assets surged 1147.67%; it then slumped 48.43% in 2024.
- Tracing PFE's Current Assets over 5 years: stood at $51.3 billion in 2022, then dropped by 15.46% to $43.3 billion in 2023, then advanced by 16.21% to $50.4 billion in 2024, then fell by 14.81% to $42.9 billion in 2025, then slipped by 0.18% to $42.8 billion in 2026.
- Per Business Quant, the three latest PFE Current Assets figures stand at $42.8 billion (Q1 2026), $42.9 billion (Q4 2025), and $46.9 billion (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Novartis Ag | 107,124,802.25 Bn | 107,124,802.25 Bn | - | - |
| 2 | Eli Lilly | 969.00 Bn | 963.72 Bn | 16.22 Bn | 54.84 Bn |
| 3 | Johnson & Johnson | 539.46 Bn | 517.41 Bn | 15.96 Bn | 59.17 Bn |
| 4 | AbbVie | 376.92 Bn | 367.57 Bn | 10.78 Bn | 33.53 Bn |
| 5 | Merck | 285.00 Bn | 279.35 Bn | 12.09 Bn | 35.02 Bn |
| 6 | Amgen | 177.58 Bn | 165.55 Bn | 5.87 Bn | 31.48 Bn |
| 7 | Gilead Sciences | 163.22 Bn | 155.50 Bn | 5.52 Bn | 18.64 Bn |
| 8 | Pfizer | 145.86 Bn | 133.09 Bn | -1.21 Bn | 42.82 Bn |
| 9 | Bristol Myers Squibb | 111.90 Bn | 101.44 Bn | 8.07 Bn | 27.21 Bn |
| 10 | Gsk | 88.34 Bn | 83.66 Bn | - | 23.29 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 29, 2026 | 42.82 Bn |
| Dec 31, 2025 | 42.90 Bn |
| Sep 28, 2025 | 46.92 Bn |
| Jun 29, 2025 | 43.70 Bn |
| Mar 30, 2025 | 45.86 Bn |
| Dec 31, 2024 | 50.36 Bn |
| Sep 29, 2024 | 43.22 Bn |
| Jun 30, 2024 | 37.83 Bn |
| Mar 31, 2024 | 42.42 Bn |
| Dec 31, 2023 | 43.33 Bn |
| Oct 1, 2023 | 74.01 Bn |
| Jul 2, 2023 | 73.35 Bn |
| Apr 2, 2023 | 50.08 Bn |
| Dec 31, 2022 | 51.26 Bn |
| Oct 2, 2022 | 5.93 Bn |
| Jul 3, 2022 | 67.47 Bn |
| Apr 3, 2022 | 54.42 Bn |
| Dec 31, 2021 | 59.69 Bn |
| Oct 3, 2021 | 6.89 Bn |
| Jul 4, 2021 | 48.81 Bn |
| Apr 4, 2021 | 39.53 Bn |
| Dec 31, 2020 | 35.07 Bn |
| Sep 27, 2020 | 6.61 Bn |
| Jun 28, 2020 | 46.42 Bn |
| Mar 29, 2020 | 34.74 Bn |
| Dec 31, 2019 | 32.80 Bn |
| Sep 29, 2019 | 7.51 Bn |
| Jun 30, 2019 | 47.07 Bn |
| Mar 31, 2019 | 45.29 Bn |
| Dec 31, 2018 | 49.93 Bn |
| Sep 30, 2018 | 41.58 Bn |
| Jul 1, 2018 | 37.30 Bn |
| Apr 1, 2018 | 34.84 Bn |
| Dec 31, 2017 | 41.14 Bn |
| Oct 1, 2017 | 40.29 Bn |
| Jul 2, 2017 | 36.39 Bn |
| Apr 2, 2017 | 35.88 Bn |
| Dec 31, 2016 | 38.95 Bn |
| Oct 2, 2016 | 38.50 Bn |
| Jul 3, 2016 | 43.85 Bn |
| Apr 3, 2016 | 41.30 Bn |
| Dec 31, 2015 | 43.80 Bn |
| Sep 27, 2015 | 45.00 Bn |
| Jun 28, 2015 | 51.72 Bn |
| Mar 29, 2015 | 49.44 Bn |
| Dec 31, 2014 | 55.60 Bn |
| Sep 28, 2014 | 56.99 Bn |
| Jun 29, 2014 | 58.29 Bn |
| Mar 30, 2014 | 57.79 Bn |
| Dec 31, 2013 | 56.24 Bn |
| Sep 29, 2013 | 59.50 Bn |
| Jun 30, 2013 | 61.44 Bn |
| Mar 31, 2013 | 64.76 Bn |
| Dec 31, 2012 | 64.83 Bn |
| Sep 30, 2012 | 57.13 Bn |
| Jul 1, 2012 | 58.77 Bn |
| Apr 1, 2012 | 54.86 Bn |
| Dec 31, 2011 | 60.82 Bn |
| Oct 2, 2011 | 62.73 Bn |
| Jul 3, 2011 | 60.48 Bn |
| Apr 3, 2011 | 58.24 Bn |
| Dec 31, 2010 | 61.01 Bn |
| Oct 3, 2010 | 54.09 Bn |
| Jul 4, 2010 | 51.10 Bn |
| Apr 4, 2010 | 49.92 Bn |
| Dec 31, 2009 | 61.67 Bn |
| Sep 27, 2009 | 73.78 Bn |
| Jun 28, 2009 | 71.55 Bn |